Edwards Lifesciences’ artificial aortic valve technology opens the way for innovative heart surgery, which promises to reduce costs, as well as patient recovery time.
Sr. Trading Analyst
Sands Capital (2015 - 2021)
Arlington, VA | Trading Analyst
Sands Capital (2012 - 2015)
Arlington, VA | Sr. Global Administrator
Bank of New York Mellon (2010 - 2012)
New York, NY | Product Derivatives Analyst
SS&C Technologies (2006 - 2010)
Windsor, CT | Derivatives Analyst
Central Connecticut State University (2006)
BS | Finance
Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines rigorous fundamental analysis with creative thinking to identify high-quality growth businesses that are creating the future. Through strategies designed to concentrate investment in these businesses, we serve the long-term growth objectives of institutions and fund sponsors in more than 40 countries.
An independent, staff-owned firm based in the Greater Washington, DC area, Sands Capital managed more than USD $68 billion in client assets as of December 31, 2020.
© 2021 Sands Capital Management. All Rights Reserved.
For institutional and professional investors only.